Search

everythinglearnresearchcommunity

for

Search:↓

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

An over-the-counter vitamin/mineral supplement improved hair loss and blood sugar control in a woman with non-classic 11-hydroxylase deficiency.

Biotin supplements may help hair regrowth in some alopecia areata patients.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Flavin prevents cataracts in young rats.

Warfarin is effective but risky, requiring careful monitoring to prevent bleeding.

CMV infection increases the risk of GvHD after bone marrow transplants.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Valproic acid can rarely cause reversible nail discoloration.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

New inhibitors may reduce gut toxicity from cancer drugs.

Ivermectin, Vimeral syrup, and Benzyl Benzoate effectively treat sarcoptic mange in rabbits.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Baricitinib significantly regrows hair in severe alopecia areata patients.

A woman recovered from hair loss and skin eruptions after stopping a tuberculosis drug and using steroids.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

The albumin change rate helps predict treatment success in AIDS-related non-Hodgkin lymphoma.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Different oral anticoagulants cause various non-bleeding side effects, so careful monitoring is needed.

Platelet- and marrow-derived biologics help heal tissues and reduce infections but need standardized methods for better use.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.